News & Events

Amid the rapid advancement of global medical technology, we are thrilled to announce remarkable progress: GenDx Biotech’s two ERA detection kits, namely the GENEYE® HP(Helicobacter pylori) ERA Assay and the GENEYE® HPVE6/E7 (Human Papillomavirus) typing Super Panel ERA Assay, have successfully obtained certifications in Indonesia. This achievement not only demonstrates GenDx Biotech’s strong R&D capabilities but also boosts confidence in global public health initiatives.

Founded in 2017, GenDx Biotech’s team has long been deeply engaged in the POCT molecular diagnostics field. Upholding the development philosophy of “Technology Innovation, Excellence Pursuit” and the core values of “Easy, Rapid, Accurate”, the company is committed to becoming an innovative leader in infectious pathogen detection technologies, ushering in a new era of efficient and accurate on-site pathogen detection across all scenarios.

With continuous investment in technological R&D, GenDx Biotech owns a number of cutting-edge technical platforms, providing solid technical support for the development of various diagnostic reagents. The certification of the HP and HPV E6/E7 detection kits marks another fruitful achievement for the company.

GenDx Biotech has always stayed true to its mission. In the future, the company will continue to increase R&D investment, further optimize existing technologies, and expand into more diagnostic fields. We believe that more advanced diagnostic reagents will be launched soon, bringing greater contributions to global public health. Let us stay tuned!